#aidrugdevelopment — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #aidrugdevelopment, aggregated by home.social.
-
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657 -
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657 -
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657 -
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657 -
SciSparc Launches Quantum Computing Drug Discovery Platform
SciSparc (NASDAQ:SPRC), a clinical-stage pharmaceutical company, announced its b…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Computing #3Dproteinmodeling #AIdrugdevelopment #biotechinitiative #drugdesign #Drugdiscovery #neurologicaldisorders #pharmaceuticaltechnology #proteinfolding #QuantumAlgorithms #Quantumcomputing #SciSparc #SPRC #structuralbiology #Technology
https://www.newsbeep.com/us/180821/ -
SciSparc Launches Quantum Computing Drug Discovery Platform
SciSparc (NASDAQ:SPRC), a clinical-stage pharmaceutical company, announced its b…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Computing #3Dproteinmodeling #AIdrugdevelopment #biotechinitiative #drugdesign #Drugdiscovery #neurologicaldisorders #pharmaceuticaltechnology #proteinfolding #QuantumAlgorithms #Quantumcomputing #SciSparc #SPRC #structuralbiology #Technology
https://www.newsbeep.com/us/180821/ -
SK Biopharmaceuticals Co. has signed an MOU with PhnyX Lab to jointly develop AI-powered solutions for automating drug discovery processes, aiming to boost global competitiveness.
#YonhapInfomax #SKBiopharmaceuticals #PhnyXLab #AIDrugDevelopment #Cheiron #MOU #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68036